What did Coloplast pay for Atos Medical?

Coloplast acquired Atos Medical for $2.53B in 2021 (27.1x EBITDA), equivalent to 9.90x revenue. Target revenue was approximately $256.5M. Target EBITDA was approximately $93.3M.

What does Atos Medical do?

Atos Medical is a medical devices business.

What multiple did Coloplast pay for Atos Medical?

27.1x EBITDA and 9.90x revenue, based on disclosed deal value of $2.53B and disclosed financials.

M&A TRANSACTION · 2021

Atos Medical acquired by Coloplast

$2.53B· 27.1x EBITDA· 9.90x revenue

Target

Atos Medical

Acquirer

Coloplast

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$256.5M

EBITDA

$93.3M

Deal Value

$2.53B

EV/EBITDA

27.1x

Context

This $2.53B acquisition of Atos Medical by Coloplast sits in the medical devices sub-vertical. The 27.1x EBITDA multiple paid in 2021 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Coloplast is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Atos Medical acquisition.

Citation: ExitValue.ai. (2021). Atos Medical acquired by Coloplast. https://exitvalue.ai/deals/atos-medical-acquired-by-coloplast-hc-2021-0082